Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

6.35USD
16 Jan 2019
Change (% chg)

$0.34 (+5.66%)
Prev Close
$6.01
Open
$6.18
Day's High
$6.35
Day's Low
$5.71
Volume
20,104
Avg. Vol
26,144
52-wk High
$6.35
52-wk Low
$2.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.252
Jun '18 0.00 -0.454
Mar '18 0.00 -1.027
FY 2017 Dec '17 0.00 -0.625
Sep '17 0.00 -0.296
Jun '17 0.00 -0.288
Mar '17 0.00 -0.079
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Quarter Ending Jun-19 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 2 -0.47 -0.40 -0.53 --
Quarter Ending Jun-19 2 -0.56 -0.40 -0.71 --
Year Ending Dec-19 2 -1.61 -1.55 -1.67 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.12 34.38
P/E High - Last 5 Yrs. -- 40.55 46.19
P/E Low - Last 5 Yrs. -- 23.99 24.58
Beta -- 0.91 0.91
Price to Sales (TTM) -- 4.00 6.26
Price to Book (MRQ) 2.07 5.02 5.20
Price to Tangible Book (MRQ) 2.07 5.76 6.73
Price to Cash Flow (TTM) -- 23.21 24.17
% Owned Institutions 0.28 0.94 1.75

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.22 4.93
Payout Ratio(TTM) -- 45.69 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.31 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 6.48
Sales - 5 Yr. Growth Rate -- 10.00 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago -212.06 17.44 23.23
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.50
Capital Spending - 5 Yr. Growth Rate -- 15.23 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.30
Current Ratio (MRQ) 4.85 3.02 3.12
LT Debt to Equity (MRQ) 1.45 8.85 11.47
Total Debt to Equity (MRQ) 23.49 12.66 16.03
Interest Coverage (TTM) -- 35.18 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.40 54.45
Gross Margin - 5 Yr. Avg. -- 51.85 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.40 13.10
Operating Margin (TTM) -- 14.43 6.05
Operating Margin - 5 Yr. Avg. -- 14.54 8.39
Pre-Tax Margin (TTM) -- 14.96 7.01
Pre-Tax Margin - 5 Yr. Avg. -- 14.97 8.67
Net Profit Margin (TTM) -- 11.16 3.11
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.86
Effective Tax Rate (TTM) -- 23.47 23.27
Effective Tax Rate - 5 Yr. Avg. -- 23.66 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 997,645,050 873,304,610
Net Income/Employee (TTM) -- 118,307,527 103,509,255
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.57
Asset Turnover (TTM) -- 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.99 11.45
Return on Assets - 5 Yr. Avg. -- 13.28 12.50
Return on Investment (TTM) -- 15.55 14.96
Return on Investment - 5 Yr. Avg. -- 17.29 16.23
Return on Equity (TTM) -- 16.93 16.53
Return on Equity - 5 Yr. Avg. -- 18.21 17.36
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 39.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.09%
# of Holders: 11
Total Shares Held: 222,314
3 Mo. Net Change: -950
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.